All In MedTech

Device Trial Radar · NCT07152808

Clinical Study for TONOREF III Tested to ANSI Z80.10-2014

Clinical Pilot Study to Provide Research Data for TONOREF III Tested to ANSI Z80.10-2014

Last checked: Nov 19, 2026Latest source record: Apr 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

52

Actual

Start

Sep 2, 2022

Primary completion

Jun 19, 2023

Study completion Jun 19, 2023

Sponsor

Lead sponsor
Nidek Co. LTD.Not on our public-company list
Sponsor type
Industry
First posted
Sep 3, 2025

More device trials from this sponsor

Design

Study type
Interventional
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes, from 22 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The primary objective of this clinical study was to show that tonometry values for TONOREF III, as the representative device of the NIDEK tonometer series, were comparable to the predicate device. The secondary objective was to demonstrate that the test device was as safe as the predicate device.

Conditions

  • Intraocular Pressure

Interventions

  • NIDEK TONOREF IIIDevice

    The auto ref/kerato/tono/pachymeter TONOREF III is a medical device which measures objective refractive errors, corneal curvature radius, intraocular pressure and corneal thickness of the patient's eye.

  • Haag-Streit Goldmann Manual TonometerDevice

    Haag-Streit Goldmann Manual Tonometer measures intraocular pressure to aid in the screening and diagnosis of glaucoma

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Agreement of Intraocular PressureTime frame: 1-2 study visits per subject over the course of 8 days

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.